智通财经APP讯，同仁堂医养(02667)公布，有关全球发售的稳定价格期已于2026年8月1日(星期六)(即递交香港公开发售申请截止日期后第30日)结束。
稳定价格经办人中国国际金融香港证券有限公司或其联属人士或代其行事的任何人士于稳定价格期采取的稳定价格行动载列如下： 在国际发售中超额分配合540.75万股H股，占超额配股权获行使前全球发售项下初步可供认购发售股份总数约5.0%;于稳定价格期间在市场上按每股H股2.69港元至4.76港元的价格连续买入合共540.75万股H股。
独家整体协调人(为其本身及代表国际承销商)于稳定价格期内并无行使超额配股权，而超额配股权已于2026年8月1日(星期六)失效。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.